Autres langues TELA Bio, Inc.

Actions

TELA

US8723811084

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 02/05/2024			Varia. 5j.	Varia. 1 janv.
4,63 ^USD	0,00%		+5,47%	-30,06%

15/04	TELA Bio, Inc. annonce le lancement commercial aux États-Unis d'OviTex IHR, compatible avec la robotique	CI
22/03	TELA BIO, INC. : Opinion positive de Piper Sandler	ZM

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Morgans rates ARX as Add	01/05
TELA Bio to Announce First Quarter 2024 Financial Results	25/04
TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex IHR, Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures	16/04
TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures	15/04
TELA Bio, Inc. Announces U.S. Commercial Launch of Robotic-Compatible OviTex IHR	15/04
TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy	08/04
Earnings Flash (TELA) TELA BIO Reports Q4 Revenue $17M, vs. Street Est of $16.4M	21/03
TELA Bio, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	21/03
TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Results	21/03
TELA Bio, Inc. Provides Revenue Guidance for the Full Year 2024	21/03
TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery	21/03
TELA Bio, Inc. Announces U.S. Commercial Launch of LIQUIFIX	21/03
MiMedx Group to Buy Distribution Rights for TELA Bio's Wound Care Product	20/03
MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing	20/03
TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX	20/03
MiMedx Group, Inc. Enters into an Agreement with Tela Bio, Inc. to Obtain Exclusive Rights to Its Manufacturing and Supply Agreement	20/03
TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results	29/02
TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results	29/02
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	23/02
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	19/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues TELA Bio, Inc.

Actions

TELA

US8723811084

Autres langues

Filtres